Clark Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$752K Buy
5,144
+23
+0.4% +$3.18K 0.39% 39
2026
Q2
$662K Sell
5,121
-168
-3% -$19.7K 0.37% 43
2026
Q1
$641K Buy
5,289
+491
+10% +$56.7K 0.43% 34
2025
Q4
$505K Hold
4,798
– – 0.31% 41
2025
Q3
$505K Sell
4,798
-1,542
-24% -$127K 0.31% 41
2025
Q2
$502K Buy
6,340
+109
+2% +$8.66K 0.34% 38
2025
Q1
$559K Buy
6,231
+350
+6% +$32.7K 0.41% 35
2024
Q4
$585K Buy
+5,881
New +$606K 0.45% 33

Other funds holding MRK

Clark Wealth Partners's MRK Position: Q3 2026 in Review

Clark Wealth Partners increased its Merck (MRK) stake by 0.45% in Q3 2026, buying an estimated $3.18K and bringing the position to 5,144 shares worth $752K. The position accounts for 0.39% of the portfolio, ranked #39.

Clark Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Clark Wealth Partners held 5,144 shares of Merck worth $752K as of Q3 2026.
  • Clark Wealth Partners bought 23 Merck shares in Q3 2026, an estimated $3.18K.
  • Merck made up 0.39% of Clark Wealth Partners's portfolio in Q3 2026, its #39 holding.
  • Clark Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.